Research Overview: Cenforce-200 Sildenafil Citrate
Cenforce-200 is a sildenafil citrate research compound manufactured by Centurion Laboratories, specifically designed for in-vitro laboratory investigations examining PDE-5 inhibitor mechanisms. This pharmaceutical-grade research chemical enables scientists to study vascular smooth muscle relaxation pathways and nitric oxide signaling cascades in controlled laboratory environments. Researchers at Stroid UK Shop utilize this compound to investigate cyclic GMP regulation and phosphodiesterase enzyme interactions within cellular research models.
Laboratory Research Applications
Scientific studies examine Cenforce-200’s molecular interactions with phosphodiesterase type 5 enzymes, analyzing how selective inhibition affects intracellular signaling pathways. Cardiovascular research laboratories investigate this compound’s influence on smooth muscle cell relaxation mechanisms and endothelial function studies. Researchers studying sildenafil citrate compounds analyze its effects on nitric oxide-mediated vasodilation processes in tissue culture experiments. Comparative studies evaluate this compound alongside other research chemicals from the SARMs category to understand receptor selectivity differences. Laboratory investigations also examine potential interactions with various peptide research compounds in cellular signaling pathway studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Concentration | 200mg per tablet |
| Manufacturer | Centurion Laboratories |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| CAS Number | 139755-83-2 |
| Molecular Weight | 666.7 g/mol |
| Storage | Room temperature, dry conditions |
| Research Use | In-vitro laboratory studies only |
Research Compliance Statement
This research compound is manufactured exclusively for scientific research and laboratory analysis purposes. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must comply with institutional safety protocols and obtain appropriate permits for handling pharmaceutical research chemicals. All studies must be conducted in properly equipped laboratory facilities with adequate safety measures and waste disposal procedures.
